BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Solulink, Inc. 

9853 Pacific Heights Boulevard
Suite H
San Diego  California  92121  U.S.A.
Phone: 858-625-0670 Fax: 858-625-0770


SEARCH JOBS




Industry
Suppliers






 Company News
Solulink, Inc. Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer 9/11/2013 7:16:03 AM
Former Life Technologies (LIFE) and BD Biosciences (BDX) Executive John L. "Kip" Miller Joins Solulink, Inc.'s Board of Directors 8/29/2013 6:22:30 AM
Solulink, Inc. Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody-Labeling Technology 7/18/2013 9:33:36 AM
Solulink, Inc. Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody Labeling Technology 7/17/2013 12:37:35 PM
SoluLinK, Inc. Announces IRS Federal Grant Award to Advance its New Multiplexing and Detection Technology for Research and Diagnostics Applications Used for Accelerating Therapeutics Development 9/15/2011 12:06:53 PM
SoluLinK, Inc. Awarded Phase I SBIR Contract to Develop a Multiplex Screen for the Rapid Detection of Breast Cancer 9/15/2011 12:04:33 PM
SoluLinK, Inc. Awarded SBIR NIAID Phase I Grant for Development of a Multiplexed Vaccine Titer Assay 9/15/2011 11:59:29 AM
SoluLinK, Inc. Introduces First-Ever Kits for Antibody-Oligonucleotide Preparation without Chromatography 9/15/2011 11:57:18 AM
SoluLinK, Inc. Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100% Yields 9/15/2011 11:55:27 AM
SoluLinK, Inc. Introduces First-Ever Digoxigenin Antibody Labeling Kit with Built-in Quantification 9/15/2011 11:44:33 AM
12